Dec 2016 $2 M No. 6 Under $2 million 5
Tarsa Therapeutics, Inc.: Raise no. 6, Dec 2016 × Investors in this round 5 investors had bought by the notice of Jan 13, 2017: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Brand · Executive Officer, Director Gregory Lumpkin · Executive Officer Lewis Geffen · Executive Officer Eric Bednarski · Director James Tananbaum · Director Martin Edwards · Director Richard Kollender · Director Richard Levy · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David Brand, President & CEO. Source: SEC Form D, newest notice filed Jan 13, 2017. Read the notice at the SEC .
debt, options SEC Jun 2016 $1 M No. 5 Under $2 million 7
Tarsa Therapeutics, Inc.: Raise no. 5, Jun 2016 × Investors in this round 7 investors had bought by the notice of Jul 14, 2016: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Brand · Executive Officer, Director Gregory Lumpkin · Executive Officer Lewis Geffen · Executive Officer Derek Ferguson · Director Eric Bednarski · Director James Tananbaum · Director Martin Edwards · Director Richard Kollender · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David Brand, President & CEO. Source: SEC Form D, newest notice filed Jul 14, 2016. Read the notice at the SEC .
debt, options SEC Feb 2016 $2 M No. 4 $2 to $10 million 7
Tarsa Therapeutics, Inc.: Raise no. 4, Feb 2016 × Investors in this round 7 investors had bought by the notice of Feb 19, 2016: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Brand · Executive Officer, Director Gregory Lumpkin · Executive Officer Lewis Geffen · Executive Officer Derek Ferguson · Director Eric Bednarski · Director James Tananbaum · Director Martin Edwards · Director Richard Kollender · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David Brand, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 19, 2016. Read the notice at the SEC .
debt, options SEC Mar 2012 $14 M No. 3 $10 to $50 million 5
Tarsa Therapeutics, Inc.: Raise no. 3, Mar 2012 × Investors in this round 5 investors had bought by the notice of Mar 22, 2012: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $14 M of $28 M offered; $14 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice David Brand · Executive Officer, Director Gregory Lumpkin · Executive Officer Lewis Geffen · Executive Officer Ashleigh Palmer · Director Eric Bednarski · Director James Tananbaum · Director Martin Edwards · Director Matthew Rieke · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David Brand, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 22, 2012. Read the notice at the SEC .
equity, options SEC Sep 2010 $16 M No. 2 $10 to $50 million 7
Tarsa Therapeutics, Inc.: Raise no. 2, Sep 2010 × Investors in this round 7 investors had bought by the notice of Apr 21, 2011: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $16 M of $25 M offered; $9 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice David Brand · Executive Officer, Director Ashleigh Palmer · Director Eric Bednarski · Director Martin Edwards · Director Matthew Rieke · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David Brand, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Apr 21, 2011. Read the notice at the SEC .
debt, options SEC Oct 2009 $12 M No. 1 $10 to $50 million 5
Tarsa Therapeutics, Inc.: Raise no. 1, Oct 2009 × Investors in this round 5 investors had bought by the notice of Oct 27, 2009: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $12 M of $24 M offered; $12 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Brand · Executive Officer, Director Eric Bednarski · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David Brand, President/CEO. Source: SEC Form D, newest notice filed Oct 27, 2009. Read the notice at the SEC .
equity SEC